ANBL1821: A Phase 2 Randomised Study of Irinotecan/Temozolomide/Dinutuximab with or without Eflornithine (DFMO) (IND# TBD) in Children with Relapsed& Refractory or Progressive Neuroblastoma

Viewing: QLD

Filter by

Trial Stage
  • Trial Stage
  • Closed to Recruitment
  • In Development
  • Open
  • Preparing to Open
Location
  • Location
  • New Zealand
  • NSW
  • QLD
  • SA
  • TAS
  • VIC
  • WA
Disease Type
  • Disease Type
  • Bone Cancers (Ewing Sarcoma/Osteosarcoma)
  • Brain and other Central Nervous System (CNS) Tumours
  • Germ Cell Tumours
  • Hodgkin Lymphoma
  • Kidney (Renal) Tumours
  • Leukaemia
  • Liver tumours
  • Neuroblastoma
  • Non-Hodgkin Lymphoma
  • Other
  • Soft Tissue Sarcomas
Disease Stage
  • Disease Stage
  • Newly diagnosed
  • Other
  • Relapsed/Recurrent

ANBL1821: A Phase 2 Randomised Study...

Neuroblastoma
Status: Open | New Zealand, NSW, QLD, SA, VIC, WA

Relapsed/Recurrent
Read more

TiNT: A phase II study of...

Bone Cancers (Ewing Sarcoma/Osteosarcoma), Brain and other Central Nervous System (CNS) Tumours, Germ Cell Tumours, Kidney (Renal) Tumours, Liver tumours, Neuroblastoma, Soft Tissue Sarcomas
Status: Open | New Zealand, NSW, QLD, SA, TAS, VIC, WA

Relapsed/Recurrent
Read more

APAL2020SC: Pediatric Acute Leukemia (PedAL) Screening...

Leukaemia, Other
Status: Open | New Zealand, NSW, QLD, VIC, WA

Relapsed/Recurrent
Read more

ANZUP 1302: Phase 3 Accelerated BEP...

Germ Cell Tumours
Status: Open | New Zealand, QLD

Newly diagnosed
Read more

TPX-0005-07: A phase 1/2, open-label safety,...

Bone Cancers (Ewing Sarcoma/Osteosarcoma), Brain and other Central Nervous System (CNS) Tumours, Germ Cell Tumours, Kidney (Renal) Tumours, Liver tumours, Neuroblastoma, Soft Tissue Sarcomas
Status: Open | NSW, QLD, WA

Relapsed/Recurrent
Read more

ZERO2: Precision Medicine for Every Child...

Bone Cancers (Ewing Sarcoma/Osteosarcoma), Brain and other Central Nervous System (CNS) Tumours, Germ Cell Tumours, Hodgkin Lymphoma, Kidney (Renal) Tumours, Leukaemia, Liver tumours, Neuroblastoma, Non-Hodgkin Lymphoma, Other, Soft Tissue Sarcomas
Status: Open | New Zealand, NSW, QLD, SA, TAS, VIC, WA

Newly diagnosed, Relapsed/Recurrent
Read more

OPTIMISE: Optimal Precision TherapIes to CustoMISE...

Bone Cancers (Ewing Sarcoma/Osteosarcoma), Brain and other Central Nervous System (CNS) Tumours, Germ Cell Tumours, Hodgkin Lymphoma, Kidney (Renal) Tumours, Liver tumours, Neuroblastoma, Non-Hodgkin Lymphoma, Soft Tissue Sarcomas
Status: Open | NSW, QLD, VIC, WA

Relapsed/Recurrent
Read more

APEC14B1: Project: EveryChild A Registry and...

Bone Cancers (Ewing Sarcoma/Osteosarcoma), Brain and other Central Nervous System (CNS) Tumours, Germ Cell Tumours, Hodgkin Lymphoma, Kidney (Renal) Tumours, Leukaemia, Liver tumours, Neuroblastoma, Non-Hodgkin Lymphoma, Other, Soft Tissue Sarcomas
Status: Open | New Zealand, NSW, QLD, SA, VIC, WA

Newly diagnosed
Read more

EFC16295: A Phase 3 Open-label, Multicenter...

Other
Status: Open | QLD

Relapsed/Recurrent
Read more

All posts loaded.

All posts loaded.

Join our newsletter

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Email info@anzchog.org   |  

Level 6, TRF Building, Hudson Institute, 27-31 Wright St, Clayton VIC 3168

ANZCHOG acknowledges Traditional Owners of Country throughout Australia and recognises the continuing connection to lands, waters and communities. We pay our respect to Aboriginal and Torres Strait Islander cultures, and to Elders both past and present. We acknowledge Māori as tangata whenua of Aotearoa New Zealand and as Treaty partners with the Crown as agreed in Te Tiriti o Waitangi. 

We are committed to creating a safe and welcoming environment that embraces all backgrounds, cultures, sexualities, genders and abilities.